Immunomodulatory role of Tinospora cordifolia as an adjuvant in surgical treatment of diabetic foot ulcers: A prospective randomized controlled study

Indian Journal of Medical Sciences

Volumn 61, Issue 6, 2007, Pages 347-355

  Purandare, Harshad ^a   Supe, Avinash ^a,b  

^a KEM HOSPITAL   (India)

^b Sangeeta Towers   (India)

Author keywords

Diabetic foot ulcers; Immunomodulation

Indexed keywords

PLACEBO; TINOSPORA CORDIFOLIA EXTRACT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DIABETIC FOOT; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EDEMA; ERYTHEMA; FEMALE; FIBROSIS; GLYCEMIC CONTROL; GRANULATION TISSUE; HUMAN; IMMUNOMODULATION; MALE; MEDICINAL PLANT; NEUTROPHIL; ODOR; PAIN; PARAMETER; PHAGOCYTOSIS; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TINOSPORA; TINOSPORA CORDIFOLIA; ULCER HEALING; WOUND ASSESSMENT; WOUND CARE; WOUND HEALING;

EID: 34250178792     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.32682     Document Type: Article

References (14)

1. Shobhana R, Rao PR, Lavanya A, Vijay V, Ramachandran A. Footcare economics-cost burden to diabetic patients with foot complications: A study from Southern India. J Assoc Physicians India 2001;49:530-3.
2. Viswanathan V, Shobhana R, Snehalatha C, Seena R, Ramachandran A. Need for education on footcare in diabetic patients in India. J Assoc Physicians India 1999;47:1083-5.
3. The cost of Diabetes mellitus. WHO Fact Sheeth No. 312, Sept 2006.
4. Steed DL. The role of growth factors in wound healing. Surg Clin North Am 1997;77:575-86.
5. Steel DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 2006;117:143S-9S.
6. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998;21:822-7.
7. Thatte UM, Rao SG, Dahanukar SA. Tinospora cordifolia induces colony-stimulating activity in serum. J Postgrad Med 1994;40:202-3.
8. Dahanukar SA, Thatte UM, Pai N, More PB, Karandikar SM. Immunotherapeutic modification by Tinospora cordifolia of abdominal sepsis induced by caecal ligation in rats. Indian J Gastroenterol 1998;7:21-5.
9. Armstrong DG, Lavery LA, Frykberg RG, Wu SC, Boulton AJ. Validation of a diabetic foot surgery classification. Int Wound J 2006;3:240-6.
10. Reiber GE, Raugi GJ. Preventing foot ulcers and amputations in diabetes. Lancet 2005;366:1676-7.
11. Thatte UM, Kulkarni MR, Dahanukar SA. Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by Tinospora cordifolia. J Postgrad Med 1992;38:13-5.
12. Steed DL, Donohoe D, Webster MW, Lindsley L. Effects of extensive debridement on the healing of diabetic foot ulcers. J Am Coll Surg 1996;183:61-4.
13. Katiyar CK, et al. Immunomodulatory products from Ayurveda: Current status and future perspectives. In: Immunomodulation. Upadhyay SN, editors. Narosa Publishing House: New Delhi; 1997. p. 163.
14. Brem H, Sheehan P, Rosenberg HJ, Schneider JS, Boulton AJ. Evidence-based protocol for diabetic foot ulcers. Plast Reconstr Surg 2006;117:193S-209S.